Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8639560rdf:typepubmed:Citationlld:pubmed
pubmed-article:8639560lifeskim:mentionsumls-concept:C0218989lld:lifeskim
pubmed-article:8639560lifeskim:mentionsumls-concept:C0282534lld:lifeskim
pubmed-article:8639560lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:8639560lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:8639560lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:8639560lifeskim:mentionsumls-concept:C0450363lld:lifeskim
pubmed-article:8639560pubmed:issue20lld:pubmed
pubmed-article:8639560pubmed:dateCreated1996-7-15lld:pubmed
pubmed-article:8639560pubmed:abstractTextSignal transduction in B cells is mediated, in part, by the interaction of the cytoplasmic components of the antigen receptor complex and various members of the src family tyrosine kinases. Key to this process appears to be the interaction of the tyrosine kinase SH2 domains with the tyrosine-phosphorylated cytoplasmic domain of Ig-alpha, a disulfide-bonded heterodimeric (with Ig-beta or Ig-gamma) transmembrane protein that noncovalently associates with the antigen receptor immunoglobin chains. In addition to binding to the phosphorylated cytoplasmic domains of Ig-alpha and Ig-beta, blk and fyn(T), two members of the src family kinases, have been shown to bind overlapping but distinct sets of phosphoproteins [Malek & Desiderio (1993) J. Biol. Chem. 268. 22557-22565]. A comparison of their three-dimensional structures may elucidate the apparently subtle differences required for phosphoprotein discrimination. To begin characterizing the blk/fyn/phosphosphoprotein interactions, we have determined the three-dimensional solution structure of the SH2 domain of blk kinase by nuclear magnetic resonance (NMR) spectroscopy. 1H, 13C, and 15N resonances of the SH2 domain of blk kinase were assigned by analysis of multidimensional, double- and triple-resonance NMR experiments. Twenty structures of the blk SH2 domain were refined with the program X-PLOR using a total of 2080 experimentally derived conformational restraints. The structures converged to a root-mean-squared (rms) distance deviation of 0.51 and 0.95 A for the backbone atoms and for the non-hydrogen atoms, respectively. The blk SH2 domain adopts the prototypical SH2 fold. Structurally, blk SH2 is most similar to the crystal structure of the v-src SH2 domain [Waksman et al. (1993) Nature 358.646-653] and superimposes on the crystal structure with an rmsd of 1.52 A for the backbone atoms. The largest deviations occur in the four loops interconnecting beta-strands A-E, which are the least well-defined regions in the NMR structure. Exclusion of these loops lowers this rmsd to 0.82 A. The conformation of the BC loop in the blk SH2 domain is similar to the open conformation in the apo lck SH2 domain, suggesting that, like the lck SH2 domain, the blk SH2 domain may have a gated phosphopeptide binding site. Finally, it is proposed that the amino acid substitution of Lys 88 (blk) for Glu [fyn(T)] is important for the observed differences in specificity between blk and fyn(T) SH2 domains.lld:pubmed
pubmed-article:8639560pubmed:languageenglld:pubmed
pubmed-article:8639560pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:citationSubsetIMlld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8639560pubmed:statusMEDLINElld:pubmed
pubmed-article:8639560pubmed:monthMaylld:pubmed
pubmed-article:8639560pubmed:issn0006-2960lld:pubmed
pubmed-article:8639560pubmed:authorpubmed-author:MuellerLLlld:pubmed
pubmed-article:8639560pubmed:authorpubmed-author:LeitingBBlld:pubmed
pubmed-article:8639560pubmed:authorpubmed-author:MetzlerW JWJlld:pubmed
pubmed-article:8639560pubmed:authorpubmed-author:FarmerB...lld:pubmed
pubmed-article:8639560pubmed:authorpubmed-author:PryorKKlld:pubmed
pubmed-article:8639560pubmed:issnTypePrintlld:pubmed
pubmed-article:8639560pubmed:day21lld:pubmed
pubmed-article:8639560pubmed:volume35lld:pubmed
pubmed-article:8639560pubmed:ownerNLMlld:pubmed
pubmed-article:8639560pubmed:authorsCompleteYlld:pubmed
pubmed-article:8639560pubmed:pagination6201-11lld:pubmed
pubmed-article:8639560pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:meshHeadingpubmed-meshheading:8639560-...lld:pubmed
pubmed-article:8639560pubmed:year1996lld:pubmed
pubmed-article:8639560pubmed:articleTitleThe three-dimensional solution structure of the SH2 domain from p55blk kinase.lld:pubmed
pubmed-article:8639560pubmed:affiliationDepartment of Macromolecular NMR, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000, USA.lld:pubmed
pubmed-article:8639560pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8639560pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:12143entrezgene:pubmedpubmed-article:8639560lld:entrezgene